What Researchers Did
In a single-centre, retrospective, case-controlled study, researchers assessed the effect of hyperbaric oxygen therapy (HBOT) on mortality in 341 patients with necrotising fasciitis over a 13-year period.
What They Found
Overall mortality was 14.4%, with 12% in patients treated with HBOT compared to 24.3% in those not treated. HBOT was independently associated with a significant reduction in mortality (odds ratio 0.42, P=0.01), even after adjusting for illness severity. Increased age and immunosuppression were also independent factors impacting mortality.
Canadian Relevance
This study was conducted in Australia and does not have a direct Canadian connection.
Study Limitations
The retrospective, single-centre design of this study limits the generalizability of its findings and introduces potential for selection bias.